Article
Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection…
Therapeutics and Clinical Risk Management · 2016 · Ayzenberg I, Hoepner R, Kleiter I
Key facts
| Title | Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations |
|---|---|
| First author | Ayzenberg I, Hoepner R, Kleiter I |
| Journal | Therapeutics and Clinical Risk Management |
| Published | Feb 19, 2016 |
| DOI | 10.2147/TCRM.S65558 |
| Devices mentioned | K801080, K851935, K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185 and 3 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, KLB, KLS and 4 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1